GLYSCEND
Live / Registered — Registered (as of 01 Nov 2022)
What this means for you
Registered since 01 Nov 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 01 Nov 2028: the §8 declaration of use).
Record
- Serial number
- 90708693
- Registration number
- 6890734
- Mark type
- Word mark
- Filed
- 13 May 2021
- Published for opposition
- 14 Jun 2022
- Registered
- 01 Nov 2022
- Next maintenance filing
- §8 declaration of use, due by 01 Nov 2028 (grace period to 01 May 2029)
- Attorney of record
- MICHAEL N. MERCANTI
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of metabolic diseases including diabetes
Owner
- Glyscend, Inc., Lowell, MA, US
- Glyscend, Inc., Lowell, MA, US
- Glyscend, Inc., Lowell, MA, US
Prosecution history
- 30 Jun 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jun 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Dec 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Dec 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Dec 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Nov 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Nov 2022 — REGISTERED-PRINCIPAL REGISTER
- 30 Sept 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 29 Sept 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Sept 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Aug 2022 — USE AMENDMENT FILED
- 12 Sept 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Aug 2022 — TEAS STATEMENT OF USE RECEIVED
- 09 Aug 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT